Curcumin Nanoparticle Enhances the Anticancer Effect of Cisplatin by Inhibiting PI3K/AKT and JAK/STAT3 Pathway in Rat Ovarian Carcinoma Induced by DMBA

Cisplatin has been used for decades for the treatment of ovarian cancer. However, despite its potent anticancer effect, cisplatin’s efficacy as a single agent was inadequate in patients with advanced stage. Curcumin has been shown to sensitize cisplatin activity in several cancer models. However, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandhiutami, Ni Made Dwi, Arozal, Wawaimuli, Louisa, Melva, Rahmat, Deni, Wuyung, Puspita Eka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848208/
https://www.ncbi.nlm.nih.gov/pubmed/33536913
http://dx.doi.org/10.3389/fphar.2020.603235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848208/
https://www.ncbi.nlm.nih.gov/pubmed/33536913
http://dx.doi.org/10.3389/fphar.2020.603235

Ejemplares similares